Arkolith/Insider Trading/OLMA/Form 4

BVF Partners OS Ltd.

DirectorOlema Pharmaceuticals, Inc. (OLMA) · full profile →Form 4 · filed Jan 14, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 10, 2025Disposed to issuer(D)162K——2.0M
Jan 10, 2025Disposed to issuer(D)235K——2.7M
Jan 10, 2025Disposed to issuer(D)23K——348K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 10, 2025Grant(A)162K——2.6M
Jan 10, 2025Grant(A)235K——3.3M
Jan 10, 2025Grant(A)23K——336K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-000106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Olema Pharmaceuticals, Inc.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp